2021/2013(INI)
A Pharmaceutical Strategy for Europe
Basic information
2021/2013(INI)
INI - Own-initiative procedure
Subject
4.20.04 Pharmaceutical products and industry
Status
Procedure completed
Key players
-
European Parliament
Committee responsible Rapporteur Appointed MONTSERRAT Dolors (EPP)
17/02/2021
Committee for opinion Rapporteur for opinion Appointed ITREBOTENGA Marc (The Left)
08/02/2021
The committee decided not to give an opinion. The committee decided not to give an opinion. JURIREGIMENTI Luisa (ID)
18/03/2021
-
European Commission
Commission DG Commissioner Health and Food Safety KYRIAKIDES Stella
Key events
Date | Event | Reference | Summary |
---|---|---|---|
11/03/2021 | Committee referral announced in Parliament | ||
11/03/2021 | Referral to associated committees announced in Parliament | ||
12/10/2021 | Vote in committee | ||
08/11/2021 | Committee report tabled for plenary | A9-0317/2021 | |
22/11/2021 | Debate in Parliament | ||
23/11/2021 | Results of vote in Parliament | ||
24/11/2021 | Decision by Parliament | T9-0470/2021 |
Technical information
Procedure | Information |
---|---|
Procedure reference | 2021/2013(INI) |
Procedure type | INI - Own-initiative procedure |
Nature of procedure | Initiative |
Legal basis | Rules of Procedure EP 57_o Rules of Procedure EP 55 |
Other legal basis | Rules of Procedure EP 165 |
Stage reached in procedure | Procedure completed |
Committee dossier |
ENVI/9/05419
|
Documentation gateway
-
Document type Committee Reference Date Summary Committee draft report PE681.109 03/05/2021 Amendments tabled in committee PE692.747 02/06/2021 Amendments tabled in committee PE693.696 03/06/2021 Amendments tabled in committee PE693.845 10/06/2021 Committee opinion JURI PE692.709 14/07/2021 Committee opinion ITRE PE689.816 07/10/2021 Committee report tabled for plenary, single reading A9-0317/2021 08/11/2021 Text adopted by Parliament, single reading T9-0470/2021 24/11/2021 -
Document type Reference Date Summary Commission response to text adopted in plenary SP(2022)49 18/03/2022
Transparency
Meetings with interest representatives published in line with the Rules of Procedure
-
Name Role Committee Date Interest representatives MONTSERRAT Dolors Rapporteur ENVI 19/11/2021 ASOCIACIÓN ESPAÑOLA DE MEDICAMENTOS BIOSIMILARES MONTSERRAT Dolors Rapporteur ENVI 03/11/2020 ASOCIACIÓN NACIONAL EMPRESARIAL DE LA INDUSTRIA FARMACÉUTICA